Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure.
- DOI
- 10.1586/17512433.2016.1153423
- Published
- 2016 Apr
- Container
- Expert review of clinical pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1586/17512433.2016.1153423,
title = {Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure.},
author = {Katsanos S and Bistola V and Parissis JT},
year = {2016},
journal = {Expert review of clinical pharmacology},
doi = {10.1586/17512433.2016.1153423},
url = {https://doi.org/10.1586/17512433.2016.1153423}
}RIS
TY - JOUR TI - Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure. AU - Katsanos S AU - Bistola V AU - Parissis JT PY - 2016 JO - Expert review of clinical pharmacology DO - 10.1586/17512433.2016.1153423 UR - https://doi.org/10.1586/17512433.2016.1153423 ER -
APA
S, K., V, B., & JT, P. (2016). Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure.. Expert review of clinical pharmacology. https://doi.org/10.1586/17512433.2016.1153423
Source records
- pubmed · retrieved 2026-09-26T05:41:53.048Z